CELH

Celsius Holdings, Inc.

72
Fundamentals87/ 100
Valuation70/ 100
Upside potential73/ 100
Risk potential26/ 100

CELH's fundamentals are strong and it looks cheap: trading at 35x earnings, less than half its usual 142x. Analysts expect strong earnings growth, though they disagree widely on how much.

PAVS

Paranovus Entertainment Technology Ltd.

There isn't enough reported data to score PAVS yet.

CELH Fundamentals

MetricStatus
Healthy
Strong
Stable
Strong

CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.

PAVS Fundamentals

MetricStatus
Unavailable
Under pressure
Unavailable
Strong

PAVS's balance sheet is currently strong, but its profitability is under pressure. There isn't enough data to rate its revenue and cash flow.

CELH PE Valuation

CHEAPFAIREXPENSIVE318x636x954x1272x
CHEAPFAIREXPENSIVE318x636x954x1272x
LevelPEPriceVs current
Forward21x$31.89โ€”
Current35x$31.89โ€”
Cheap40x$35.95+13%
Fair141x$127+299%
Expensive650x$585+1735%

Historical ranges are pointers, not guarantees.

CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.

PAVS PE Valuation

PAVS has no meaningful PE right now: it lost money over the past year.

CELH Forward outlook

MetricOutlook
Strongly improving
Strong growth
Growth
Improving
Limited
Low

Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.

PAVS Forward outlook

There aren't enough analyst estimates for PAVS to show an outlook.

CELH Risk to reward

ScenarioChangePrice
Upside+69%$54.01
Downside-25%$23.76

Calculated from the latest close: $31.89 on Nov 12.

There is not enough scenario data to compare CELH and PAVS's risk to reward.

PAVS Risk to reward

ScenarioChangePrice
UpsideUnknownโ€”
DownsideUnknownโ€”

Calculated from the latest close: $2.54 on Nov 12.

There is not enough scenario data to compare CELH and PAVS's risk to reward.

CELH Earnings Per Share

Q4 2023: $0.77Q1 2024: $0.91Q2 2024: $1.01Q3 2024: $0.72Q4 2024: $0.45Q1 2025: $0.33Q2 2025: $0.38Q3 2025: $0.11Q4 2025: $0.25Q1 2026: $0.43Q2 2026: $0.24Q3 2026: $0.90Forward: $1.53
Q4 2023: $0.77Q1 2024: $0.91Q2 2024: $1.01Q3 2024: $0.72Q4 2024: $0.45Q1 2025: $0.33Q2 2025: $0.38Q3 2025: $0.11Q4 2025: $0.25Q1 2026: $0.43Q2 2026: $0.24Q3 2026: $0.90Forward: $1.53
QuarterTTM EPSYoY
Forward$1.53+70%
Q3 2026$0.90+718%
Q2 2026$0.24-37%
Q1 2026$0.43+30%
Q4 2025$0.25-44%
Q3 2025$0.11-85%
Q2 2025$0.38-62%
Q1 2025$0.33-64%
Q4 2024$0.45-42%

CELH has the edge over PAVS in the latest year-over-year earnings comparison.

PAVS Earnings Per Share

Q1 2020: $1,272,000.00Q1 2021: $72,000.00Q1 2022: $-2,928,000.00Q1 2023: $-2,610,000.00Q3 2023: $-1,250,193.25Q1 2024: $-176,969.96Q1 2025: $-11,207.63
Q1 2020: $1,272,000.00Q1 2021: $72,000.00Q1 2022: $-2,928,000.00Q1 2023: $-2,610,000.00Q3 2023: $-1,250,193.25Q1 2024: $-176,969.96Q1 2025: $-11,207.63
QuarterTTM EPSYoY
Q1 2025-$11,207.63+$165,762.33
Q1 2024-$176,969.96+$2,433,030.04
Q1 2023-$2,610,000.00+$318,000.00
Q1 2022-$2,928,000.00-4167%
Q1 2021$72,000.00-94%
Q1 2020$1,272,000.00-35%

PAVS lost $11,207.63 per share over the past year, a smaller loss than the year before.

CELH Quarterly Revenue

Q4 2023: $347MQ1 2024: $356MQ2 2024: $402MQ3 2024: $266MQ4 2024: $332MQ1 2025: $329MQ2 2025: $739MQ3 2025: $725MQ4 2025: $722MQ1 2026: $783MQ2 2026: $818MQ3 2026: $847M
Q4 2023: $347MQ1 2024: $356MQ2 2024: $402MQ3 2024: $266MQ4 2024: $332MQ1 2025: $329MQ2 2025: $739MQ3 2025: $725MQ4 2025: $722MQ1 2026: $783MQ2 2026: $818MQ3 2026: $847M
QuarterRevenueYoY
Q3 2026$847.2M+17%
Q2 2026$817.9M+11%
Q1 2026$782.6M+138%
Q4 2025$721.6M+117%
Q3 2025$725.1M+173%
Q2 2025$739.3M+84%
Q1 2025$329.3M-7.4%
Q4 2024$332.2M-4.4%

CELH has the edge over PAVS in the latest year-over-year revenue comparison.

PAVS Quarterly Revenue

Q1 2020: $65MQ3 2020: $22MQ1 2021: $50MQ1 2022: $89MQ3 2022: $53MQ1 2023: $45MQ3 2023: $6MQ1 2024: $7MQ3 2024: $68,454Q1 2025: $71,542Q3 2025: $12MQ1 2026: $2M
Q1 2020: $65MQ3 2020: $22MQ1 2021: $50MQ1 2022: $89MQ3 2022: $53MQ1 2023: $45MQ3 2023: $6MQ1 2024: $7MQ3 2024: $68,454Q1 2025: $71,542Q3 2025: $12MQ1 2026: $2M
QuarterRevenueYoY
Q1 2026$2.2M+2960%
Q3 2025$12.4M+18033%
Q1 2025$71.5K-99%
Q3 2024$68.5K-99%
Q1 2024$6.5M-86%
Q3 2023$6.3M-88%
Q1 2023$45.2M-50%
Q1 2022$89.5M+80%

PAVS's revenue has slid since its 2022 peak: $2M last quarter, down 67% from the same quarter a year ago.

CELH Free Cash Flow

Q4 2023: $426,000Q1 2024: $130MQ2 2024: $30MQ3 2024: $9MQ4 2024: $70MQ1 2025: $96MQ2 2025: $35MQ3 2025: $321MQ4 2025: โˆ’$130MQ1 2026: $66MQ2 2026: $205MQ3 2026: $128M
Q4 2023: $426,000Q1 2024: $130MQ2 2024: $30MQ3 2024: $9MQ4 2024: $70MQ1 2025: $96MQ2 2025: $35MQ3 2025: $321MQ4 2025: โˆ’$130MQ1 2026: $66MQ2 2026: $205MQ3 2026: $128M
QuarterFree cash flowYoY
Q3 2026$127.7M-60%
Q2 2026$205.5M+479%
Q1 2026$65.8M-32%
Q4 2025-$130M-285%
Q3 2025$321.5M+3599%
Q2 2025$35.5M+17%
Q1 2025$96.4M-26%
Q4 2024$70.3M+16394%

CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.

PAVS Free Cash Flow

Q1 2020: $10MQ3 2020: $7MQ1 2021: โˆ’$7MQ1 2022: โˆ’$31MQ3 2022: โˆ’$8MQ1 2023: โˆ’$13MQ3 2023: --Q1 2024: โˆ’$12MQ3 2024: --Q1 2025: --Q3 2025: --Q1 2026: --
Q1 2020: $10MQ3 2020: $7MQ1 2021: โˆ’$7MQ1 2022: โˆ’$31MQ3 2022: โˆ’$8MQ1 2023: โˆ’$13MQ3 2023: --Q1 2024: โˆ’$12MQ3 2024: --Q1 2025: --Q3 2025: --Q1 2026: --
QuarterFree cash flowYoY
Q1 2024-$11.9M+$992.5K
Q1 2023-$12.9M+$17.7M
Q1 2022-$30.5M-$23.2M
Q1 2021-$7.3M-176%
Q1 2020$9.6M+54%

PAVS's free cash flow has turned negative after years in the green: โˆ’$64M over the past year.

CELH Total Shares

Q4 2023: 237MQ1 2024: 238MQ2 2024: 238MQ3 2024: 234MQ4 2024: 237MQ1 2025: 237MQ2 2025: 260MQ3 2025: 258MQ4 2025: 255MQ1 2026: 260MQ2 2026: 257MQ3 2026: 255M
Q4 2023: 237MQ1 2024: 238MQ2 2024: 238MQ3 2024: 234MQ4 2024: 237MQ1 2025: 237MQ2 2025: 260MQ3 2025: 258MQ4 2025: 255MQ1 2026: 260MQ2 2026: 257MQ3 2026: 255M
PeriodChange %Net change
Quarterly-0.8%-2M shares
1 year-1.1%-2.9M shares
3 years+7.4%+17.6M shares
5 years+8.3%+19.5M shares
Available history+32%+62.4M shares

CELH has the edge over PAVS on shareholder dilution, with a more favorable share count trend.

PAVS Total Shares

Q1 2020: 10Q3 2020: 10Q1 2021: 11Q1 2022: 17Q3 2022: 17Q3 2023: 39Q1 2024: 39Q3 2024: 209Q1 2025: 704Q3 2025: 704
Q1 2020: 10Q3 2020: 10Q1 2021: 11Q1 2022: 17Q3 2022: 17Q3 2023: 39Q1 2024: 39Q3 2024: 209Q1 2025: 704Q3 2025: 704
PeriodChange %Net change
Quarterly0%--
1 year+1705%+665 shares

PAVS has 704 diluted shares, up 1705% from a year ago.

CELH Net Leverage

Q4 2023: -2.8xQ1 2024: -2.9xQ2 2024: -2.7xQ3 2024: -3.8xQ4 2024: -5.5xQ1 2025: -7.3xQ2 2025: 1.4xQ3 2025: 0.5xQ4 2025: 1.6xQ1 2026: 0.5xQ2 2026: 0.2xQ3 2026: -0.1x
Q4 2023: -2.8xQ1 2024: -2.9xQ2 2024: -2.7xQ3 2024: -3.8xQ4 2024: -5.5xQ1 2025: -7.3xQ2 2025: 1.4xQ3 2025: 0.5xQ4 2025: 1.6xQ1 2026: 0.5xQ2 2026: 0.2xQ3 2026: -0.1x
QuarterNet LeverageStatus
Q3 2026-0.1xNet Cash
Q2 20260.2xVery low
Q1 20260.5xVery low
Q4 20251.6xHealthy
Q3 20250.5xVery low
Q2 20251.4xHealthy
Q1 2025-7.3xNet Cash
Q4 2024-5.5xNet Cash

CELH has more cash than debt.

PAVS Net Leverage

Q1 2020: -2.0xQ1 2021: -14.3x
Q1 2020: -2.0xQ1 2021: -14.3x
QuarterNet LeverageStatus
Q1 2021-14.3xNet Cash
Q1 2020-2.0xNet Cash
Q1 2019-0.6xNet Cash

PAVS has more cash than debt.

CELH Weekly Momentum

MetricValueStatus
RSI51.3Neutral
Stochastic56.8Neutral

CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).

PAVS Weekly Momentum

MetricValueStatus
RSI32.5Neutral
Stochastic7.4Oversold

PAVS's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).

CELH PE vs Consumer Defensive Sector

MetricCELHSector medianRelative
PE35x19x82% above
PE %11187 pts below

CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.

PAVS PE vs Consumer Defensive Sector

MetricPAVSSector medianRelative
PEN/A19xโ€”

PAVS has no meaningful PE right now: it lost money over the past year.

CELH Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$29.19.4% above
20 week MA$29.67.8% above
50 week MA$36.112% below
100 week MA$38.818% below
200 week MA$44.629% below

CELH has the edge over PAVS on trend strength, trading above more of its moving averages.

PAVS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$3.2923% below
20 week MA$4.4643% below
50 week MA$750.6100% below
100 week MA$62,797.4100% below
200 week MA$173,224.8100% below

PAVS is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.

CELH Yearly ROI

YearStart priceEnd priceROI
2020$1.58$14.7+832%
2021$14.7$24.9+69%
2022$24.9$35.6+43%
2023$35.6$54.5+53%
2024$54.5$26.5-51%
2025$26.5$45.6+72%
2026 YTD$45.6$31.9-30%

CELH has the edge over PAVS on returns for 2026, with the stronger performance.

PAVS Yearly ROI

YearStart priceEnd priceROI
2020$10,032,000.0$4,392,000.0-56%
2021$4,392,000.0$1,284,000.0-71%
2022$1,284,000.0$489,600.0-62%
2023$489,600.0$295,200.0-40%
2024$295,200.0$158,400.0-46%
2025$158,400.0$2,604.0-98%
2026 YTD$2,604.0$2.54-100%

PAVS has finished every year since 2020 lower, and it's down 100% so far in 2026.

Give your agent the market.

Get API key